Piedmont Oncology Launches Sherron Berg Program for Enhanced Pancreatic Cancer Early Detection

### Advancements in Early Detection: Piedmont Oncology’s New Initiative

Piedmont Oncology announces a transformative philanthropic donation aimed at significantly enhancing its Early Detection Pancreatic Cancer Clinic (EDC). This generous investment will facilitate improved clinical operations and support crucial research initiatives. The clinic will undergo a rebranding to honor the donor, becoming the Sherron Berg Early Detection Pancreatic Cancer Program. Additionally, the designated clinical space will be renamed the Sherron Berg Surgical Oncology and Hepato-Pancreato Biliary (HPB) Surgery Clinic. This dual focus on enhancement and recognition highlights the growing emphasis on early detection in the fight against one of the most aggressive forms of cancer.

Dr. Andrew Page, the clinic’s founder and newly appointed Sherron Berg Endowed Medical Director, expresses optimism about the potential of this donation. He underscores the clinic's continued need for philanthropic support to sustain its ambitious goals. The named endowed position signifies a commitment to not only advance clinical care but also foster innovative research initiatives. The need for early detection in pancreatic cancer is critical, given its status as the fourth-leading cause of cancer-related deaths in the United States, with a five-year survival rate of only 13%, according to the American Cancer Society. This initiative aligns perfectly with the clinic's mission to promote awareness and facilitate timely intervention for patients afflicted by this formidable disease.

The Sherron Berg Early Detection Pancreatic Cancer Program stands out as Georgia's first dedicated clinic of its kind, which opened in November 2025 at Piedmont Atlanta Hospital. It provides comprehensive risk assessments and enhances access to advanced treatment options for both patients and clinicians. With a strong focus on collaborative research partnerships, the clinic aims to position itself at the forefront of innovative solutions for pancreatic cancer. Encouraged by ongoing support, the program is poised to make impactful strides in early detection and treatment methodologies.

In addition to the transformation of the EDC, contributions can be made to the Sherron Berg Early Detection Pancreatic Cancer Program through its dedicated website. Access to the clinic is available for patients through referrals or self-referrals, promoting greater engagement and awareness. The Berg family’s experience and commitment underscore the urgent need for advancements in knowledge and care surrounding pancreatic cancer, ultimately illuminating a path toward more hopeful outcomes for future patients.